The very long chain polyunsaturated fatty acids C18, C20, C22

advertisement
N-3 Omega-The Miracles of Today’s Nutrition. What
about future.?
Dr. Ugur Gogus
Middle East Technical University
Vocational School of Higher Education
Tel: +903122103653
Fax:+903122101239
gugur@metu.edu.tr
The very long chain
polyunsaturated fatty
acids
C18, C20, C22
Health
ω
15
12
9
COOH
Alpha-linolenic acid (omega -3)
12
9
COOH
ω
Linoleic acid (omega-6)
Arachidonic acid 14
the highest double bond locant
20
total C #
20-14:6(ω6)
Oleic acid
18- 9: 9(ω9)
ω
15
12
9
COOH
Alpha-linolenic acid (omega -3)
12
ω
Prostaglandins
9
COOH
Linoleic acid (omega-6)
blood vessels
blood circulation
body functions
n-6 omega PUFAs
Linoleic acid(LA)
PGE2;
TXA2
Arachidonic acid(AA)
Leukotriene B4
IL-2
IL-6
neutrophil
recruitment
immunosuppressive
free oxygen radicals
vascular permeability
platelet aggregation
odema
thrombogenesis and inflammation
TNF
IL-1
EFA
cholesterol
cytochrome P450
AA(n-6)
Brain
steroid hormone
LN(n-3)
Dihomo α-LN(n-3)
Sugar transfer
CTH hormone
LA(n-6)
reduce
PGE2;
produce
1 series eicosanoids
awakening
LTB4
neutrophil rec.
IL-2
IL-6
reduce
TXA3 + LTB5
TXA2
IL-1
Vasc.perm, platelet agg, odema
PGE3 Inflammation
PGE1 PGD2
PGI3
Sleep promoter
EPA(C20:5)&DHA(C22:6)
TNF
AA%
AA/LN
conversion rate
inflammation
dihomo α linolenic acid (LN)%
TNF
n-3 omega restoration
T-suppressor cell amount
antiinflammatory effect
eczema
psoriasis
rheumatoid arthritis
IBD
Chron’s disease
Stenson et al.(1992)/Hawthorne et al.(1992)
Colon mucosa
post operative healing
amount ???
oxidation ???
Vit
E
n-3 Omega; 5.4-4.5g
AA(n-6)
LA(n-6)
PGE2
IL-1
OFR
LTB4 TNF
Hypercholesterolemic atherosclerosis
AA(n-6)
LA(n-6)
PGE2
IL-1
OFR
LTB4
TNF
Hypercholesterolemic atherosclerosis
n-3 omega oxidation(7.7 g/daily)
Oxidation of red blood cells
LDL oxidation (Nardini, 1995)
No difference(Brude et al. 1997)
Are n-3 omega fatty acids oxidants or antioxidants?
Se, carotenoid
Dietary fat
Na
Cancer
Obesity
Hypertension
alcohol
Stroke
n-3 omega
CHD
n-3 omega(5,4 g/day)
PGE2 & thromboxanes
thrombosis,fibrilation & clot formation
CH amount
HDL
2 year follow up
n-3 omega 3 g/70 Kg/7day
Schacky et al(1999)
LDL
VLDL
(Lu, Windsor and Harris, 1999)
CH
VLDL
Protein kinase C
HDL (Rader 2003; Barbeau et al. 1997;
Allman et al. 2002; Liu, Wallin &
Saldeen, 2001)
NO
(Schoene 2001; El-seweidy et al. 2002)
n-3 omega
Saturated fat(coconut)
creatin phosphokinase
MI
MI
Nageswari,Banerjee & Menon 1999)
prevention in post myocardial infarction
n-3 omega
ischemia-induced aryhtmias
<3 g/day EPA&DHA GRAS
Lee and Lip(2003)
Leaf et al(2003)
n-6 omega & n-3 omega
PCB
Linoleic acid
endothelial cell wall
Slim et al.(2001)
n-3 omega
Cellular protection
Immun system defense
NADPH oxidase
Diabetes Mellitus
plasma glucose
fructosamine
triglyseride
LDL
HDL
NO
IL-1 & TNF
n-3 omega
LDL
IL-1 & TNF
serum glucose
?
(El-seweidy et al.2002; Gavia et al. 2003)
n-3 omega
Platelet aggregation
bile flow
kidney
(Levy & Herzberg 1996)
EPA
TNF
weight gain
(Fish oil & soy bean; Fish oil)
tumorigenesis
Colorectal cancer
Pancreas cancer
PGE2
flaxseed
fish oil
soy oil
olive oil
canola oil
(Gavia et al. 2003; Gogos et al. 1998; Barber et al. 1999:
Gavia et al. 2003; Troyer& fernandes, 1996; Denmark-Wahnefried et al. 1998)
Phospholipids + PGE2







Depression
Stress
Postpartum depression
Alzheimer
Parkinson
MS
Schizophrenia

(Horrobin et al. 2002; Maes et al. 1993; Song et al. 1998;Hibbeln, 1998; Edwars et al. 1998; Peet et al. 1998;
Furukawa et al. 2002; Horribin et al. 2001)
Omega 6 / Omega 3






10/1
15/1
2.5/1
4/1
2-3/1
5/1

16.7/1
colorectal cancer
no effect
rheumatoid arthritis
asthma
(Simopoulos AP, 2002)

Flax oil 9% Sat. Fat 20% Mono Fat 17% Omega-6 54% Omega-3
Grapeseed oil 10% Sat. Fat 17% Mono. Fat 73% Omega-6 Trace Omega-3
Pumpkin Oil 9% Sat. Fat 34% Mono. Fat 42% Omega-6 15% Omega-3
Canola Oil 6% Sat. Fat 58% Mono. Fat 26% Omega-6 10% Omega-3
Safflower Oil 9% Sat. Fat 13% Mono. Fat 78% Omega-6 Trace% Omega-3
Sunflower Oil 11% Sat. Fat 20% Mono. Fat 69% Omega-6 -0% Omega-3
Sesame Oil 15% Sat. Fat 46% Mono. Fat 41% Omega-6 0% Omega-3
Corn Oil 13% Sat. Fat 25% Mono. Fat 61% Omega-6 1% Omega-3

Olive Oil 14% Sat. Fat 77% Mono. Fat 8% Omega-6 1% Omega-3

Soybean Oil 15% Sat. Fat 24% Mono. Fat 54% Omega-6 7% Omega-3

Walnut Oil 16% Sat. Fat 28% Mono. Fat 51% Omega-6 5% Omega-3
Peanut Oil 18% Sat. Fat 48% Mono. Fat 34% Omega-6 0% Omega-3
Lard 41% Sat. Fat 47% Mono. Fat 11% Omega-6 1% Omega-3
Chicken Fat 31% Sat. Fat 47% Mono. Fat 21% Omega-6 1% Omega-3
Beef Fat 52% Sat. Fat 44% Mono. Fat 3% Omega-6 1% Omega-3
Butterfat 66% Sat. Fat 30% Mono. Fat 2% Omega-6 2% Omega-3
Coconut Oil 92% Sat. Fat 6% Mono. Fat 2% Omega-6 0% Omega-3
Palm Oil 51% Sat. Fat 39% Mono. Fat 10% Omega-6 0% Omega-3
α linolenic acid Fat content/α linolenic
acid
Fat content(g/100g)
Butter
83.2
Lard
100.0
Linseed oil 100.0
Soybean oil 100.0
Rapseed oil 100.0
Walnut oil
100.0
Olive oil
100.0
Vegetable oil
80.0
Almonds
54.1
Hazelnut
61.6
Walnuts
62.5
Kale
0.90
Lettuce
0.22
Parsley
0.36
Potato
0.11
Cauliflower 0.18
Spinach
0.30
White cabbage
0.20
Wheat bran 4.65
/
α-linolenic acid(g/100g) :
1.20
0.98
102.04
54.2
1.84
7.70
12.98
9.15
10.93
13.5
0.86
2.40
0.26
0.15
6.80
0.35
2.57
0.07
0.12
0.02
0.10
1.8
0.13
0.09
0.16
29.06
69.3
7.40
625
33.3
208.07
410.6
9.19
3.14
3.00
5.5
2.31
2.22
Fat content EPA(g/100g)
DHA(g/100g)
fat
content/EPA(g/100g)+DHA(g/100g)
fat content(g/100g)
Eel
Hering
Sprat
Tuna
Salmon
Mackerel
Carp
Sardine
Swordfish
Trout
Halibut
Cod
Haddock
Lobster
Shrimp
Mussels
Anchovy
Sardine
EPA+DHA(g/100g) fat content/EPA+DHA(g/100g)
24.5
17.8
16.6
15.5
0.83
2.72
3.23
3.37
13.6
11.9
4.8
4.5
4.4
2.7
1.7
0.6
0.6
1.9
1.4
1.4
2.3
13.9
29.51
6.54
5.14
4.60
2.86
1.75
0.30
1.39
1.79
0.59
0.51
0.18
0.16
0.20
0.30
0.15
0.50
2.44
4.76
6.8
16
3.24*
2.45*
4.58
3.33*
3.33*
3.75*
9.5
4.66
9.33
4.60
5.70
Which fish for high Omega 3
education
information
Consumer
& correct
Which tablet & nutrition for consumer
health???
Cinnamon
Garlic
Parsley
Ginkgo bloba
Tebocan
Cumadin
Aspirin/coraspirin
Ginger
Omega 3
Infant nutrition/upto day 42
n-3 omega PUFAs
+ N balance
pyschomotor
+
birthweight
breast milk supl.
with omega 3 and
its effect???
(Woltil et al. 1999;Hayashi et al. 1999; Morley. 1998)
Omega & meat industry
Peroxide
poultry fed with 8-12% fish meal
(O’Keefe, Proudfoot & Ackman, 1995)
No change
lamb oxidative stress
(Ponnampalam et al, 2001)
Oxidative or nonoxidant or no change for meat products, which??
Enrichment of meat products with n-3 Ω (Raes, Smet & Demeyer, 2003)
What about serum CH & n-3Ω levels followed by consumption.??
No study on bone health!!!
Only; lenght growth
rats, fed with n-3Ω
vertebral peak load
(Sirois, Cheung & Ward, 2003)
Application points of n-3 Ω
Aerospace industry
Cardiovascular disease;
atherosclerosis,
athrial fibrilosis,
thrombose & emboly
Cancer (esp in gastrointestinal org.)
Diabetes type 2
Depression&stress
Inflammation; crohn’s disease, rheumatoid
arthritis, asthma, MS, chronic
glomerular disease, erythematıosus,
eczema, psoriasis, IBD)
Infant nutrition
Pre/post operative periods in
Alzheimer
surgery
Questions;
1 What amount DHA&EPA supl.
for
Which DHA&EPA metabolic serum levels


?
Initial n-3/n-6 omega serum levels in the patient
The DHA/EPA amount in supplementation(from food or tablet)
Most accepted recommend? (by
FAO/WHO)(Trautwein 2001)

5-10:1(n-6/n-3)
10/1
15/1
2.5/1
4/1
2-3/1
5/1
no effect
16.7/1
colorectal cancer
no effect
rheumatoid arthritis
asthma
(Simopoulos AP, 2002)






Bone&skleton health
Missing
application
Consumer
education
and correctpoints;
dose
Oxidation or antioxidation capacity
Meat hygine and nutrition
Sport industry
Cosmetic industry




















REFERENCES
Ackman, G. R. A question of balance in parenteral nutrition: have we overlooked the importance of w-6 and w-3 fatty acids.?. Nutrition. 2001; 17(11-12): 976-977.
Allman, M. A., Pang, D., Mnutr, K. M. K., Hall, D. F. & Favaloro, E. Cardiovascular risk factors and dietary plant omega-3 verus omega-6 fatty acids. Journal of the
American Dietetic Association. 1996; 96(9):A75. Suppl:1.
Arkhipenko, Yu. V. & Sazontova, T. G. Mechanisms of the cardioprotective effect of a diet enriched with w-3 polyunsaturated fatty acids. Pathophysiology. 1995; 2(3): 131140.
Arkhipenko, Yu. V. & Sazontova, T. G. Mechanisms of the cardioprotective effect of a diet enriched with w-3 polyunsaturated fatty acids. Pathophysiology. 1995; 2(3): 132.
Bajpai, P. & Bajpai, P. K. Eicosapentaenoic acid (EPA) production from microorganisms: a review. Journal of Biotechnology. 1993; 30(2):161-183.
Baker, D. G., Krauker, G. A. T. & Laposata, R. B. Z. Suppression of human synovial cell proliferation by dihomo  linolenic acid. Arthritis Rheum. 1989; 32:1273-1281.
Barbeau, M. L., Klemp, K. F., Guyton, J. R. & Rogers, K. A. Dietary fish oil. Influence on lesion regression in the porcine meodel of atherosclerosis. Atheriosclerosis,
Thrombosis, and Vascular Biology. 1997; 17(4):688-694.
Barber, M. D., Ross, J. A., Vos, A. C., Tisdale, M. J. & Fearon, K. C. H. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with
pancreatic cancer. Br. J. Cancer. 1999; 81(1): 80-86.
Bartoli, G. M., Palozza, P., Luberto, C., Franceschelli, P. & Piccioni, E. Biochemical and Biophysical Research communications. 1995; 213(3):881.
Belluzzi, A. N-3 and n-6 fatty acids for the treatment of autoimmune diseases. Eur. J. Lipid Sci. Technol. 2001; 103:399.
Braga, M., Gianotti, L., Vignali, A. & Carlo, D. V. Immunonutrition in gastric cancer surgical patients. Nutrition. 1998; 14(11-12):831-835.
Brude, L. R., Drevon, C. A., Hjerman, I., Seljeflot, I. & Nenseter, M. S. Peroxidation of low density lipoprotein from male hyperlipidemic smokers suplied with omega-3 fatty
acids and antioxidants. Atherosclerosis. 1997; 134(1-2):220.
Charalambos, A., Gogos, M. D., Ginopoulos, P. et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely
ill patients with generalized malignancy. Cancer.1998; 82(2): 395-402.
Clarke, L. H., Clarke, C. R. & Lippman, M. The inluence ofmaternal diet on breast cancer risk among female offspring. Nutrition. 1999; 15(5): 392-401.
Denmark-Wahnefried, W., Price, D. T., Polacik, T. J.et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before
surgery:exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic fetaures. Urology. 2001; 58(1):47-52.
Eder, K. & Brandsch, C. The effects of fatty acid composition of rapeseed oil on plasma lipids and oxidative stability of low-density lipoproteins in cholesterol-fed hamsters.
European Journal of Lipid Science and Technology. 2002; 104(1):3
Edwards, R., Peet, M., Shay, J. & Horrobin, D. Omega-3 polyunsaturated fatty acids in the diet and in the red blood cell membranes od depressed patients. J. Affect Disord.
1998; 48:153-155.
El-seweidy, M. M., El-swefy, S. E., Ameen, R. S. & Hashem, R. M. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation,
oxidative stress and cytokine production in stz(streptozotocin)diabetic rats. Pharmacological Research. 2002; 45(5):395-398.
El-seweidy, M. M., El-swefy, S. H., Ameen, R. S. & Hashem, R. M. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation,
oxidative stress and cytokine production in diabetic rats. Pharmacological Research. 2002; 45(5):391-398.



















Emmanuel, C. O. & Hubbard, V. S. Essential fatty acids (EFA): Role in pancreatic hormone release and concomitant metabolic effect. The Journal of Nutritional
Biochemistry. 1993; 4(9): 498.
Endres, S., Ghorbani, R., Kelley, VE., Georgilis, K., Lonnemann, G. & Van der Meer, JWM. The effect of dietary supplementation with (n-3)polyunsaturated fatty acids on
the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 1989; 320:265-73.
Furukawa, K., Yamamori, H., Tukagi, K. et. al. Influences of soybean oil emulsion on stress response and cell-mediated immune function on stress response and cellmediated immune function in moderately or severely stressed patients. Nutriition. 2002; 18(3):235-239.
Gavia, H. M., Couto, C. R., Oyama, M. L. et. al. Diets rich in polyunsaturated fatty acids effect on hepatic metabolism in rats. Nutrition. 2003; 19(2): 144.
Gavia, H. M., Couto, C. R., Oyama, M. L. et. al. Diets rich in polyunsaturated fatty acids effect on hepatic metabolism in rats. Nutrition. 2003; 19(2): 148-149.
Gil, A. Polyunsaturated fatty acids and inflammatory diseases. Biomedicine & Pharmacotherapy. 2002; 56(8): 388-396.
Gogos, A. C., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, C. N. & Kalfarentzos, F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore
immunodeficiency and prolong survival dor reversily ill patients with generalized malignancy. Cancer. 1998; 82(2):395-402.
Griffiths, M. A. Inflammatory bowel disease. Nutrition. 1998; 14(10):788-791.
Hawthorne, A. B., Daneshmend, T. K., Hawkey, C. J. et. al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 months randomized controlled
trial. Gut. 1992; 33: 922-928.
Hayashi, N., Tashiro, T., Yamamori, H. et. al. Effect of intravenous w-6 and w-3 fat emulsions on nitrogen retension and protein kinetics in burned rats. Nutrition. 1999;
15(2):135-139.
Heine, J., Scheinichen, D., Jaeger, K., Andre, M. & Leuwer, M. Invitro influence of parenteral lipid emulsions on the respiratory burst of neutrophils. Nutrition. 1999; 15(78):540-545.
Heininger, K. A unifying of Alzheimer’s disease. III. Risk Factors. Human Psychopharmacology. Clin. Exp. 2000; 15:1.
Hibbeln, J. R. Seafood consumption, the DHA content of mother’s milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. Journal of
Affective Disorders. 2002; 69(1-3):15-29.
Hibbeln, JR. 1998. Fish consumption and major depression. Lancet. 351:1213.
Horrobin, F. D. Phospholipid metabolism and depression:the possible roles of phospholipase A2 and coenzme A-indeoendent transacylase. Human
Psychopharmacology:Clinical and Experimental. 2001; 16(1):45-52.
Horrobin, D. F., Jenkins, K., Bennett, C. N. & Christie, W. W. Eicosapentaenoic acid and arachidonic acid:colloboration and not antagonism is the key to biological
understanding. Prostoglandins, Leukotriens and Essential Fatty Acids. 2002; 66(1):83-90.
Köller, M., Senkal, M., Kemen, M., König, W., Zumtobel, V. & Muhr, G. Impact of omega 3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major
surgery. Clinical Nutrition. 2003; 22(1):59-64.
Kramer, H. J., Stevens, J., Grimminger, F. & Seeger, W. Fish oil fatty acids and human platelets. Dose-dependent decrease in dienoic and increase in trienoic thromboxane
generation. Biochemical Pharmacology. 1996; 52(8): 1211-1214.
Kuhnlein, H. V., Yeboah, F., Sedgemore, M., Sedgemore, S. & Chan, H. M. Nutritional qualities of Ooligan Grease: A Traditional Food Fat of British Columbia First
Nations. Journal of Food Composition and Analysis. 1996; 9(1):18-31.


















Kusunoki, M., Tsutsumi, K., Hara, T. et. al. Ethyl icosapentate(omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF
rats. Metabolism. 2003; 52(1):30-34.
Leaf, A., Xiao, F. Y., Kang, X. J. & Billman, G. E. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacology&Therapeutics. 2003; 98(3):355-377.
Lee, KW. & Lip, GY. H. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM-AN Int. J. Of Medicine.2003; 96(7):465-480.
Levy, R. & Herzberg, G. R. Effects of a meal of fish oil or corn oil on bile flow and composition in rats previously adapted to diets containing fish oil or corn oil. Nutrition
Research. 1996; 16(5):805-816.
Linseisen, J., Hoffmann, J., Lienhard, S., Jauch, K. W. & Wolfram, G. Antioxidant status of surgical patients receiving TPN with an n-3 fatty acid containing lipid emulsion
supplemented with -tocopherol. Clinical Nutrition. 2000; 19(3): 177-178.
Linseisen, J., Hoffmann, J., Lienhard, S., Jauch, K.W. & Wolfram, G. Antioxidant status of surgical patients receiving TPN with an -3-fatty acid-containing lipid emulsion
supplemented with -tocopherol. Clinical Nutrition. 2000; 19(3):183.
Liu, M., Wallin, R. & Saldeen, T. Effect of bread containing stable fish oil on plasma phospholipid fatty acids, triglycerides, HDL-cholesterol, and malondialdehyde in subjects
with hyperlipidemia. Nutrition Research. 2001; 21(11):1403-1410.
Lox, C. D. The effects of dietary marine fish(omega-3 fatty acids)on coagulation profiles in men. General Pharmacology:The Vascular System. 1990; 21(2):241-246.
Lu, G., Windsor, S. L. & Harris, W. S. Omega-3 fatty acids after lipoprotein subfraction distributions and the in vitro conversion f very low density lipoproteins to low density
lipoproteins. The Journal of Nutritional Biochemistry. 1999; 10(3): 151-158.
Maes, M., Stevens, WJ., Declerek, LS. et. al. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression:further evidence for an
inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17:241-255.
Maes, M., Verkerk, R., Vandoolaeghe, E. et. al. Serotonin-immune interactions in major depression:lower serum tryptophan as a marker of an immune-inflammatory
response. EurArch Psychiatr Clin Neurosci. 1997; 247:154-161.
Morley, R. Nutrition and cognitive development. Nutrition. 1998; 14(10):752-754.
Nageswari, K., Banerjee, R. & Menon, V. P. Effect of saturated, w-3 and w-6 polyunsaturated fatty acids on myocardial infarction. The Journal of Nutritional Biochemistry.
1999; 10(6):338-344.
Nardini, M., D’Aquino, M. D., Gentili, V., DiFelice, M. & Scaccini, C. Dietary fish oil enhances plasma and LDL oxidative modification in rats. The Journal of Nutritional
Biochemistry. 1995; 6(9):474-480.
Nitenberg, G. & Raynard, B. Nutritional support of the cancer patient: issues and dilemmas. Critical Reviews in Oncology/Hematology. 2000; 34(3): 137-168.
Nkondjock, A., Shatenstein, B., Maisonneuve, P. & Ghadirian, P. Specific fatty acids and human colorectal cancer: an overview. Cancer detection and Prevention. 2003;
27(1): 55-66
O’Keefe, J. H. Jr. & Harris, W. S. From Inuit to implementation: Omega-3 fatty acids come of age. Mayo Clinic Proceedings. 2000; 75(6):607-610.
O’Keefe, S. F., Proudfoot, F. G. & Ackman, R. G. Lipid oxidation in meats of omega-3 fatty acid-enriched broiler chickens. Food Research International. 1995; 28(4): 151161.


















Peet, M., Murphy, B., Shay, J. & Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol psychiatry. 1998; 43:317-319.
Ponnampalam, E. N., Trout, G. R., Sinclair, A. J., Egan, A. R. & Leury, B. J. Comparison of the color stability and lipid oxidative stability of fresh and vacuum packaged lamb
muscle containing elevated omega-3 and omega-6 fatty acid levels from dietary manipulation. Meat Science. 2001; 58(2):151-161.
Prasad, K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997; 132(1): 69.
Puiggros, C., Chacon, P., Armadans, J. I., Clapes, J. & Planas, M. Effects of oleic-rich and omega-3 rich diets on serum lipid pattern and lipid oxidation in mildly
hypercholesterolemic patients. Clinical Nutrition. 2002; 21(1): 79-87.
Rader, D. J. Effects of nonstatin lipid drug therapy on high-density lipoprotein metabolism. The American Journal of Cardiology. Supl. 1. 2003; 91(7):18-23.
Raes, K., Smet, S, De. & Demeyer, D. Available on line 23 October 2003. Effect of dietary fatty acids as incorparation of long chain polyunsaturated fatty acids and
conjugated linolenic acid in lamb, beef and pork meat: a review. Animal Feed Science and Technology, In Press, Corrected Proof.
Retterstol, K., Stugaard, M., Gorbitz, C. & Ose, L. Results of intensive long-term treatment of familial hypercholesterolemia. The American Journal of Cardiology. 1996;
78(12):1369-1374.
Rokka, T., Allen, K., Valaja, J. & Ryhanen, E.-L. The effect of a Camelina sativa enriched diet on the composition and sensory quality of hen eggs. Food Research
International. 2002; 35(2-3):254-256.
Santoli, D., Phillips, P. D., Colt, T. L. & Zurier, R. B. Suppression of interleukin-2 dependent human T cell growth by E-series prostaglandins (PGE) and their precursor fatty
acids:evidence for a PGE-independent mechanism of inhibition by the fatty acids. J. Clin. Invest. 1990; 35:424-432.
Sauci., Fahman & Kraut. Food Composition and Nutrition Tables, 5th. Ed. 1994.
Schacky, C., Angerer, P., Kothny, W., Theisen, K. & Mudra, H. The effect of dieatry omega-3 fatty acdis on coronary atherosclerosis. A randomized, double-blind, placebocontrolled trial. Annals of Internal Medicine. 1999; 130(7):561-562.
Schoene, N. W. Beyond deficiency:new roles for vitamins. Vitamin E and w-3 fatty acids:effectors of platelet responsiveness. Nutrition. 2001; 17(10):793-796.
Shoda, R., Matsueda, K., Yamato, S. & Umeda, N. Epidemiologic analysis of Chron disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal
protein relates to the increased incidence of chron disease in Japan. Am. J. Clin. Nutr. 1996; 63(5):741-745.
Sidhu, K. S. Health benefits and potential risks related to consumption of fish or fish oil. Regulatory Toxicology and Pharmacology. 2003; 38(3):336
Simopoulos, Ap., Kifer, RR. Martin, RE. & Barlow, SM. Health effects of w-3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet. 1991; 66:488-503.
Sirous, I., Cheung, A. M. & Ward, E. W. Biochemical bone strenght and bone mass in young male and female rats fed a fish oil diet. Prostaglandins, Leukotrienes and
Essential fatty acids. 2003; 68(6):415-421.
Slim, R., Hammock, D. B., Toborek, M., Robertson, W. L., Newman, W. J., Morisseau, H. P. C., Watkins, A. B., Saraswathi, V. & Hennig, B. The role of Methyl-linoleic acid
epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicology and Applied Pharmacology. 2001;
17(3): 184-193.
Song, C., Lin, A., Bonaccorso, S. et. al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep desorders and major
depression. J. Affect Disord. 1998; 49:211-219.


















Stenson, W. F., Cort, D., Rodgers, J. et. al. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med.1992; 116:609-614.
Sweeney, C., Freeman, J., Gee, D. L. et. al. Changes in coronary heart disease risk among Japanese exchange students. Journal of American
Dietetic Association. Supp:1. 1999; 99(9):A77.
Tapiero, H., Nguyen Ba, G., Couvreur, P. & Tew, K. D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and
pathologies. Biomedicine & Pharmacotherapy. 2002; 56(5): 216.
Temple, J. N. Nutrition and disease:challenges of research design. Nutrition. 2002; 18(4):343.
Temple, N. J. Nutrition and disease:challenges of research design. Nutrition. 2002; 18(4):343-345.
Temple, NJ. Dietary fats and coronary heart disease. Biomedicine & Pharmacotherapy. 1996; 50(6-7):261-268.
Trautwein, E. A. N-3 Fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103: 47.
Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:45.
Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:51.
Trautwein, E. A. N-3 fatty acids-physiological and technical aspects for their use in food. Eur. J. Lipid Sci. Technol. 2001; 103:52.
Troyer, D. & Fernandes, G. Nutrition and apoptosis. Nutrition Research. 1996; 16(11-12): 1959-1987.
Turner, D. N., Braby, L. A., Ford, J. & Lupton, R. J. Nutrition. Opportunities for nutritional amelioration of radiation of radiation-induced
cellular damage. 2002; 18(10):904-912
Villa, B., Calabresi, L., Chiesa, G., Rise, P., Galli, C. & Sirtori, C. R. Omega-3 fatty acid ethyl esters increase heart rate variability in patients
with coronary disease. Pharmacological Research. 2002; 45(6):475-478.
Wahlqvist, M. L. Nutritional pathways to coronary heart disease. Atherosclerosis. 1998;136(1):528.
Warriss, P. D. Fats. Meat Science. An Introductory Text. CABI Publishing, UK. 2001: 46.
Weber, P. & Raederstorff, D. Triglyceride lowering effect of omega-3 LC-polyunsaturated fatty acids-a review. Nutrition, Metabolism, and
Cardiovascular Diseases: NMCD. 2000; 10(1):28-37.
Woltil, H. A., Beusekom, C. M., Okken-Beukens, M., Schaafsma, A., Muskiet, F. A. J. & Okken, A. Development of low-birthweight infants
at 19 months of age correlates with early intake and status of long chain polyunsaturated fatty acids. Prostaglandins, Lekotrienes and Essential
Fatty Acids. 1999; 61(4): 235-241.
Wood, O. L., Spark, A. & Spark, A. Medical nutrition therapy guidelines for treating the breast cancer patient. Journal of the American
Dietetic Association. 1996; 96(9): A35. Suppl: 1.






Wojenski, C. M., Silver, M. J. and Walker, J. Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil.
Biochimica et Biophysica Acta(BBA)-Lipids and Lipid Metabolism. 1991; 108(1):33-38.
Yahia, A. D., Madani, S., Savelli, L. J., Prost, J., Bouchenak, M. & Belleville, J. Dietary fish protein lowers blood pressure and alters tissue
polyunsaturated fatty acid composition in spontaneously hypertensive rats. Nutrition. 2003; 19(4):342-346.
Yehuda, S., Rabinovitz, S. & Mostofsky, D. I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of
Neuroscience Research. 1999; 56:565.
Yehuda, S., Rabinovitz, S. & Mostofsky, D. I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of
Neuroscience Research. 1999; 56:566.
Zimmerman, J. Optimal nutrition for HIV/AIDS Welness. Journal of the American Dietetic Association. 1997; 97(9):A18 Suppl: 1
Zyriax, B. C. & Windler, E. Dietary fat in the prevention of cardiovascular disease-a review. Eur. J. Lipid Sci. Technol. 2000; 355
Many thanks for all of you for your
participation and listening☺
gugur@metu.edu.tr
Download